NanoString Technologies Inc NSTG:NASDAQ

Last Price$13.15NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.45(3.54%)
Bid (Size)$12.50 (21)
Ask (Size)$13.30 (3)
Day Low / High$12.73 - 13.29
Volume668.6 K
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

NanoString Technologies Inc ( NASDAQ )

Price: $13.15
Change: +0.45 (3.54%)
Volume: 668.6 K
4:00PM ET 7/01/2022
 
 

Coherus BioSciences Inc ( NASDAQ )

Price: $7.83
Change: +0.59 (8.15%)
Volume: 826.6 K
4:00PM ET 7/01/2022
 
 

Sangamo Therapeutics Inc ( NASDAQ )

Price: $4.28
Change: +0.14 (3.38%)
Volume: 1.3 M
4:00PM ET 7/01/2022
 
 

Geron Corp ( NASDAQ )

Price: $1.67
Change: +0.12 (7.74%)
Volume: 3.6 M
4:00PM ET 7/01/2022
 
 

AnaptysBio Inc ( NASDAQ )

Price: $20.47
Change: +0.17 (0.84%)
Volume: 191.0 K
4:00PM ET 7/01/2022
 

Read more news Recent News

-- Earnings Flash (NSTG) NANOSTRING TECHNOLOGIES Reports Q1 Revenue $31.1M
4:04PM ET 5/10/2022 MT Newswires

...

-- Earnings Flash (NSTG) NANOSTRING TECHNOLOGIES Posts Q1 Loss $-0.86
4:03PM ET 5/10/2022 MT Newswires

...

After Hours Watch List Scorecard: NAVB, LQDA, NSTG
5:16PM ET 4/13/2022 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session: AFTER HOURS REGULAR SESSION NAVB +11.8% ...

Sector Update: Health Care Stocks Putting Up Modest Gains This Afternoon
4:05PM ET 4/13/2022 MT Newswires

Health care stocks were ending moderately higher this afternoon, with the NYSE Health Care Index rising 0.3% and the SPDR Health Care Select Sector ETF...

Company Profile

Business DescriptionNanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA. View company web site for more details
Address530 Fairview Avenue North
Seattle, Washington 98109
Phone+1.888.358.6266
Number of Employees476
Recent SEC Filing06/21/20224
President, Chief Executive Officer & DirectorRobert Bradley Gray
Senior Vice President-OperationsMark A. Winham
Chief Financial OfficerKenneth Thomas Bailey
Chief Science Officer & SVP-Research & DevelopmentJoseph M. Beechem

Company Highlights

Price Open$12.73
Previous Close$12.70
52 Week Range$11.81 - 65.40
Market Capitalization$610.4 M
Shares Outstanding46.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.78
Beta vs. S&P 500N/A
Revenue$106.7 M
Net Profit Margin-87.89%
Return on Equity-68.57%

Analyst Ratings as of 03/23/2022

Buy
4
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset